The Federal Register

Ammar Sabbagh; Denial of Application

Tue, Dec 4 2007 11:00:00 GMT

On June 12, 2006, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, issued an Order to Show Cause to Ammar Sabbagh (Respondent), of Sheridan, Oregon. The Show Cause Order proposed the denial of Respondent's pending application for a DEA Certificate of Registration as a distributor of the list I chemicals ephedrine and pseudoephedrine, on the ground that his ``registration would be inconsistent with the public interest.'' Show Cause Order at 1 (quoting 21 U.S.C. 823(h)).

More specifically, the Show Cause Order alleged that on November 4, 2005, Respondent pled guilty to conspiring to distribute
pseudoephedrine, in violation of 21 U.S.C. 841(c)(2)(3), and 846. Id. at 2. The Show Cause Order thus alleged that Respondent's proposed sales of list I chemical products would be inconsistent with the public interest. Id. The Show Cause Order further informed Respondent of his right to request a hearing on the allegations. Id.

On June 19, 2006, th

Manufacturer of Controlled Substances; Notice of Registration

Tue, Dec 4 2007 11:00:00 GMT

By Notice dated August 16, 2007, and published in the Federal Register on August 27, 2007 (72 FR 49018), Boehringer Ingelheim Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
Methadone (9250)........................... II
Methadone Intermediate (9254).............. II
Dextropropoxyphene, bulk (nondosage forms) II
(9273).

Fentanyl (9801)............................ II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals.

No comments or objections have been received. DEA has considered

Manufacturer of Controlled Substances; Notice of Registration

Tue, Dec 4 2007 11:00:00 GMT

By Notice dated August 16, 2007, and published in the Federal Register on August 28, 2007, (72 FR 4931549316), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:
[[Page 68194]]
Drug Schedule Cathinone (1235)................................. I
Methcathinone (1237)............................. I
NEthylamphetamine (1475)........................ I
N,NDimethylamphetamine (1480)................... I
Aminorex (1585).................................. I
4Methylaminorex (cis isomer) (1590)............. I
GammaHydroxybutyric acid (2010)................. I
Methaqualone (2565).............................. I
AlphaEthyltryptamine (7249)..................... I
Lysergic acid diethylamide (7315)................ I
Marihuana (7360)...............

Manufacturer of Controlled Substances; Notice of Registration

Tue, Dec 4 2007 11:00:00 GMT

By Notice dated July 31, 2007, and published in the Federal Register on August 9, 2007, (72 FR 4486044861), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Lisdexamfetamine (1205).................... II

Remifentanil (9739)........................ II

The company plans to manufacture the listed controlled substances in bulk for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chattem Chemicals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals, Inc. to ensure that the company's registr

Importer of Controlled Substances; Notice of Registration

Tue, Dec 4 2007 11:00:00 GMT

By Notice dated September 21, 2007 and published in the Federal Register on September 27, 2007, (72 FR 54930), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
[[Page 68196]]
Drug Schedule Methamphetamine (1105)..................... II
Phenylacetone (8501)....................... II
Raw Opium (9600)........................... II

Poppy Straw Concentrate (9670)............. II

The company plans to import the listed controlled substances to manufacture bulk controlled substances for sale to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Chattem Chemicals, Inc. to import the basic classes of controlled substances i

Manufacturer of Controlled Substances; Notice of Registration

Tue, Dec 4 2007 11:00:00 GMT

By Notice dated August 16, 2007, and published in the Federal Register on August 27, 2007, (72 FR 49020), Chemic Laboratories, Inc., 480 Neponset Street, Building 7, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II.

The company plans to manufacture small quantities of the above listed controlled substance for distribution to its customers for the purpose of research.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemic Laboratories, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and tes